{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T13:56:40Z","timestamp":1782223000983,"version":"3.54.5"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"DOI":"10.1007\/s11030-026-11629-9","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T13:35:08Z","timestamp":1782221708000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multi-omics investigation of per- and polyfluoroalkyl substances in lung adenocarcinoma: comprehensive network toxicology, machine learning and molecular docking experiments"],"prefix":"10.1007","author":[{"given":"Chunhong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirong","family":"Nong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"issue":"5","key":"11629_CR1","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41568-025-00791-1","volume":"25","author":"SA Mazzilli","year":"2025","unstructured":"Mazzilli SA, Rahal Z, Rouhani MJ et al (2025) Translating premalignant biology to accelerate non-small-cell lung cancer interception. Nat Rev Cancer 25(5):379\u2013392. https:\/\/doi.org\/10.1038\/s41568-025-00791-1","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"11629_CR2","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/s2213-2600(24)00428-4","volume":"13","author":"G Luo","year":"2025","unstructured":"Luo G, Zhang Y, Rumgay H et al (2025) Estimated worldwide variation and trends in incidence of lung cancer by histological subtype in 2022 and over time: a population-based study. Lancet Respiratory Med 13(4):348\u2013363. https:\/\/doi.org\/10.1016\/s2213-2600(24)00428-4","journal-title":"Lancet Respiratory Med"},{"issue":"11","key":"11629_CR3","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1039\/d1em00228g","volume":"23","author":"Y Cao","year":"2021","unstructured":"Cao Y, Ng C (2021) Absorption, distribution, and toxicity of per- and polyfluoroalkyl substances (PFAS) in the brain: a review. Environ Sci Processes impacts 23(11):1623\u20131640. https:\/\/doi.org\/10.1039\/d1em00228g","journal-title":"Environ Sci Processes impacts"},{"issue":"12","key":"11629_CR4","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1007\/s10661-024-13334-2","volume":"196","author":"AM Elgarahy","year":"2024","unstructured":"Elgarahy AM, Eloffy MG, Saber AN et al (2024) Exploring the sources, occurrence, transformation, toxicity, monitoring, and remediation strategies of per- and polyfluoroalkyl substances: a review. Environ Monit Assess 196(12):1209. https:\/\/doi.org\/10.1007\/s10661-024-13334-2","journal-title":"Environ Monit Assess"},{"issue":"3","key":"11629_CR5","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1002\/etc.4890","volume":"40","author":"SE Fenton","year":"2021","unstructured":"Fenton SE, Ducatman A, Boobis A et al (2021) Per- and polyfluoroalkyl substance toxicity and human health review: current state of knowledge and strategies for informing future research. Environ Toxicol Chem 40(3):606\u2013630. https:\/\/doi.org\/10.1002\/etc.4890","journal-title":"Environ Toxicol Chem"},{"issue":"1","key":"11629_CR6","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/s1470-2045(23)00622-8","volume":"25","author":"S Zahm","year":"2024","unstructured":"Zahm S, Bonde JP, Chiu WA et al (2024) Carcinogenicity of perfluorooctanoic acid and perfluorooctanesulfonic acid. Lancet Oncol 25(1):16\u201317. https:\/\/doi.org\/10.1016\/s1470-2045(23)00622-8","journal-title":"Lancet Oncol"},{"key":"11629_CR7","doi-asserted-by":"publisher","first-page":"104831","DOI":"10.1016\/j.ebiom.2023.104831","volume":"97","author":"M van Gerwen","year":"2023","unstructured":"van Gerwen M, Colicino E, Guan H et al (2023) Per- and polyfluoroalkyl substances (PFAS) exposure and thyroid cancer risk. EBioMedicine 97:104831. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104831","journal-title":"EBioMedicine"},{"issue":"50","key":"11629_CR8","doi-asserted-by":"publisher","first-page":"21016","DOI":"10.1021\/acs.est.3c04844","volume":"57","author":"J Zheng","year":"2023","unstructured":"Zheng J, Sun B, Berardi D et al (2023) Perfluorooctanesulfonic acid and perfluorooctanoic acid promote migration of three-dimensional colorectal cancer spheroids. Environ Sci Technol 57(50):21016\u201321028. https:\/\/doi.org\/10.1021\/acs.est.3c04844","journal-title":"Environ Sci Technol"},{"issue":"50","key":"11629_CR9","doi-asserted-by":"publisher","first-page":"22027","DOI":"10.1021\/acs.est.4c08669","volume":"58","author":"J Hong","year":"2024","unstructured":"Hong J, Du K, Zhang W et al (2024) PFOS and its commercial alternative, 6:2 Cl-PFESA, induce multidrug resistance in pancreatic cancer. Environ Sci Technol 58(50):22027\u201322038. https:\/\/doi.org\/10.1021\/acs.est.4c08669","journal-title":"Environ Sci Technol"},{"key":"11629_CR10","doi-asserted-by":"publisher","first-page":"108582","DOI":"10.1016\/j.envint.2024.108582","volume":"186","author":"J Hong","year":"2024","unstructured":"Hong J, Du K, Jin H et al (2024) Evidence of promoting effects of 6:2 Cl-PFESA on hepatocellular carcinoma proliferation in humans: An ideal alternative for PFOS in terms of environmental health? Environ Int 186:108582. https:\/\/doi.org\/10.1016\/j.envint.2024.108582","journal-title":"Environ Int"},{"key":"11629_CR11","doi-asserted-by":"publisher","first-page":"137613","DOI":"10.1016\/j.jhazmat.2025.137613","volume":"489","author":"B Sun","year":"2025","unstructured":"Sun B, Zhao Y, Yang S et al (2025) Celecoxib as a potential treatment for hepatocellular carcinoma in populations exposed to high PFAS levels. J Hazard Mater 489:137613. https:\/\/doi.org\/10.1016\/j.jhazmat.2025.137613","journal-title":"J Hazard Mater"},{"issue":"51","key":"11629_CR12","doi-asserted-by":"publisher","first-page":"e2408575121","DOI":"10.1073\/pnas.2408575121","volume":"121","author":"J Mei","year":"2024","unstructured":"Mei J, Jiang J, Li Z et al (2024) Increased perfluorooctanoic acid accumulation facilitates the migration and invasion of lung cancer cells via remodeling cell mechanics. Proc Natl Acad Sci USA 121(51):e2408575121. https:\/\/doi.org\/10.1073\/pnas.2408575121","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"11629_CR13","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3390\/toxics8040112","volume":"8","author":"M Jabeen","year":"2020","unstructured":"Jabeen M, Fayyaz M, Irudayaraj J (2020) Epigenetic modifications, and alterations in cell cycle and apoptosis pathway in A549 lung carcinoma cell line upon exposure to perfluoroalkyl substances. Toxics 8(4):112. https:\/\/doi.org\/10.3390\/toxics8040112","journal-title":"Toxics"},{"issue":"8","key":"11629_CR14","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1093\/nar\/gkv1507","volume":"44","author":"A Colaprico","year":"2016","unstructured":"Colaprico A, Silva TC, Olsen C et al (2016) TCGAbiolinks: an R\/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res 44(8):e71. https:\/\/doi.org\/10.1093\/nar\/gkv1507","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"11629_CR15","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","volume":"28","author":"A Mayakonda","year":"2018","unstructured":"Mayakonda A, Lin DC, Assenov Y et al (2018) Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res 28(11):1747\u20131756. https:\/\/doi.org\/10.1101\/gr.239244.118","journal-title":"Genome Res"},{"issue":"10031","key":"11629_CR16","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1016\/s0140-6736(16)00561-4","volume":"387","author":"JE Rosenberg","year":"2016","unstructured":"Rosenberg JE, Hoffman-Censits J, Powles T et al (2016) Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial. Lancet (London England) 387(10031):1909\u20131920. https:\/\/doi.org\/10.1016\/s0140-6736(16)00561-4","journal-title":"Lancet (London England)"},{"issue":"7693","key":"11629_CR17","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","volume":"554","author":"S Mariathasan","year":"2018","unstructured":"Mariathasan S, Turley SJ, Nickles D et al (2018) TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature 554(7693):544\u2013548. https:\/\/doi.org\/10.1038\/nature25501","journal-title":"Nature"},{"issue":"8","key":"11629_CR18","doi-asserted-by":"publisher","first-page":"5122","DOI":"10.1097\/js9.0000000000002632","volume":"111","author":"Y Hong","year":"2025","unstructured":"Hong Y, Li J, Qiu Y et al (2025) Integrative in silico analysis of per- and polyfluorinated alkyl substances (PFAS)-associated molecular alterations in human cancers: a multi-cancer framework for predicting toxicogenomic disruption. Int J Surg (London England) 111(8):5122\u20135136. https:\/\/doi.org\/10.1097\/js9.0000000000002632","journal-title":"Int J Surg (London England)"},{"issue":"20","key":"11629_CR19","doi-asserted-by":"publisher","first-page":"e39419","DOI":"10.1016\/j.heliyon.2024.e39419","volume":"10","author":"L Chen","year":"2024","unstructured":"Chen L, Liang S, Li J et al (2024) Analyzing the impact of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) on the reproductive system using network toxicology and molecular docking. Heliyon 10(20):e39419. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e39419","journal-title":"Heliyon"},{"issue":"3","key":"11629_CR20","doi-asserted-by":"publisher","first-page":"100141","DOI":"10.1016\/j.xinn.2021.100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, Hu E, Xu S et al (2021) clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innov (Cambridge (Mass)) 2(3):100141. https:\/\/doi.org\/10.1016\/j.xinn.2021.100141","journal-title":"Innov (Cambridge (Mass))"},{"issue":"22\u201323","key":"11629_CR21","doi-asserted-by":"publisher","first-page":"5539","DOI":"10.1093\/bioinformatics\/btaa1018","volume":"36","author":"X Lu","year":"2021","unstructured":"Lu X, Meng J, Zhou Y et al (2021) MOVICS: an R package for multi-omics integration and visualization in cancer subtyping. Bioinf (Oxford England) 36(22\u201323):5539\u20135541. https:\/\/doi.org\/10.1093\/bioinformatics\/btaa1018","journal-title":"Bioinf (Oxford England)"},{"issue":"8","key":"11629_CR22","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.1172\/jci91095","volume":"127","author":"J Jeschke","year":"2017","unstructured":"Jeschke J, Bizet M, Desmedt C et al (2017) DNA methylation-based immune response signature improves patient diagnosis in multiple cancers. J Clin Investig 127(8):3090\u20133102. https:\/\/doi.org\/10.1172\/jci91095","journal-title":"J Clin Investig"},{"issue":"9","key":"11629_CR23","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1007\/s12094-024-03439-y","volume":"26","author":"C Li","year":"2024","unstructured":"Li C, Hu J, Jiang X et al (2024) Identification and validation of an immune-derived multiple programmed cell death index for predicting clinical outcomes, molecular subtyping, and drug sensitivity in lung adenocarcinoma. Clin translational oncology: official publication Federation Span Oncol Soc Natl Cancer Inst Mexico 26(9):2274\u20132295. https:\/\/doi.org\/10.1007\/s12094-024-03439-y","journal-title":"Clin translational oncology: official publication Federation Span Oncol Soc Natl Cancer Inst Mexico"},{"issue":"12","key":"11629_CR24","doi-asserted-by":"publisher","first-page":"i197","DOI":"10.1093\/bioinformatics\/btv268","volume":"31","author":"F Petralia","year":"2015","unstructured":"Petralia F, Wang P, Yang J et al (2015) Integrative random forest for gene regulatory network inference. Bioinf (Oxford England) 31(12):i197\u2013205. https:\/\/doi.org\/10.1093\/bioinformatics\/btv268","journal-title":"Bioinf (Oxford England)"},{"key":"11629_CR25","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ins.2013.07.007","volume":"250","author":"V L\u00f3pez","year":"2013","unstructured":"L\u00f3pez V, Fern\u00e1ndez A, Garc\u00eda S et al (2013) An insight into classification with imbalanced data: empirical results and current trends on using data intrinsic characteristics. Inf Sci 250:113\u2013141. https:\/\/doi.org\/10.1016\/j.ins.2013.07.007","journal-title":"Inf Sci"},{"key":"11629_CR26","doi-asserted-by":"publisher","unstructured":"Zhang J, Li H, Tao W et al (2025) GseaVis: an R package for enhanced visualization of gene set enrichment analysis in biomedicine. Med Res n\/a(n\/a) https:\/\/doi.org\/10.1002\/mdr2.70000","DOI":"10.1002\/mdr2.70000"},{"key":"11629_CR27","doi-asserted-by":"publisher","first-page":"687975","DOI":"10.3389\/fimmu.2021.687975","volume":"12","author":"D Zeng","year":"2021","unstructured":"Zeng D, Ye Z, Shen R et al (2021) IOBR: multi-omics immuno-oncology biological research to decode tumor microenvironment and signatures. Front Immunol 12:687975. https:\/\/doi.org\/10.3389\/fimmu.2021.687975","journal-title":"Front Immunol"},{"issue":"1","key":"11629_CR28","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","volume":"18","author":"P Charoentong","year":"2017","unstructured":"Charoentong P, Finotello F, Angelova M et al (2017) Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade. Cell Rep 18(1):248\u2013262. https:\/\/doi.org\/10.1016\/j.celrep.2016.12.019","journal-title":"Cell Rep"},{"issue":"10","key":"11629_CR29","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang P, Gu S, Pan D et al (2018) Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med 24(10):1550\u20131558. https:\/\/doi.org\/10.1038\/s41591-018-0136-1","journal-title":"Nat Med"},{"issue":"1","key":"11629_CR30","doi-asserted-by":"publisher","first-page":"4278","DOI":"10.1038\/s41467-019-12159-9","volume":"10","author":"H Jung","year":"2019","unstructured":"Jung H, Kim HS, Kim JY et al (2019) DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load. Nat Commun 10(1):4278. https:\/\/doi.org\/10.1038\/s41467-019-12159-9","journal-title":"Nat Commun"},{"issue":"1","key":"11629_CR31","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cell.2016.02.065","volume":"165","author":"W Hugo","year":"2016","unstructured":"Hugo W, Zaretsky JM, Sun L et al (2016) Genomic and transcriptomic features of response to Anti-PD-1 therapy in metastatic melanoma. Cell 165(1):35\u201344. https:\/\/doi.org\/10.1016\/j.cell.2016.02.065","journal-title":"Cell"},{"issue":"4","key":"11629_CR32","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.cell.2017.09.028","volume":"171","author":"N Riaz","year":"2017","unstructured":"Riaz N, Havel JJ, Makarov V et al (2017) Tumor and microenvironment evolution during immunotherapy with nivolumab. Cell 171(4):934\u2013949e916. https:\/\/doi.org\/10.1016\/j.cell.2017.09.028","journal-title":"Cell"},{"key":"11629_CR33","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbab260","author":"D Maeser","year":"2021","unstructured":"Maeser D, Gruener RF, Huang RS (2021) oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief Bioinform https:\/\/doi.org\/10.1093\/bib\/bbab260","journal-title":"Brief Bioinform"},{"issue":"14","key":"11629_CR34","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1158\/0008-5472.Can-12-1370","volume":"72","author":"WC Reinhold","year":"2012","unstructured":"Reinhold WC, Sunshine M, Liu H et al (2012) CellMiner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set. Cancer Res 72(14):3499\u20133511. https:\/\/doi.org\/10.1158\/0008-5472.Can-12-1370","journal-title":"Cancer Res"},{"issue":"21","key":"11629_CR35","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.1093\/bioinformatics\/bty411","volume":"34","author":"CJ Liu","year":"2018","unstructured":"Liu CJ, Hu FF, Xia MX et al (2018) GSCALite: a web server for gene set cancer analysis. Bioinf (Oxford England) 34(21):3771\u20133772. https:\/\/doi.org\/10.1093\/bioinformatics\/bty411","journal-title":"Bioinf (Oxford England)"},{"key":"11629_CR36","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.chemosphere.2016.11.127","volume":"171","author":"P Favreau","year":"2017","unstructured":"Favreau P, Poncioni-Rothlisberger C, Place BJ et al (2017) Multianalyte profiling of per- and polyfluoroalkyl substances (PFASs) in liquid commercial products. Chemosphere 171:491\u2013501. https:\/\/doi.org\/10.1016\/j.chemosphere.2016.11.127","journal-title":"Chemosphere"},{"issue":"9","key":"11629_CR37","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1080\/19440049.2023.2240908","volume":"40","author":"P Boisacq","year":"2023","unstructured":"Boisacq P, De Keuster M, Prinsen E et al (2023) Assessment of poly- and perfluoroalkyl substances (PFAS) in commercially available drinking straws using targeted and suspect screening approaches. Food Addit Contaminants Part A, Chem Anal Control. Exposure risk Assess 40(9):1230\u20131241. https:\/\/doi.org\/10.1080\/19440049.2023.2240908","journal-title":"exposure risk Assess"},{"key":"11629_CR38","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.envint.2013.06.004","volume":"59","author":"F P\u00e9rez","year":"2013","unstructured":"P\u00e9rez F, Nadal M, Navarro-Ortega A et al (2013) Accumulation of perfluoroalkyl substances in human tissues. Environ Int 59:354\u2013362. https:\/\/doi.org\/10.1016\/j.envint.2013.06.004","journal-title":"Environ Int"},{"key":"11629_CR39","doi-asserted-by":"publisher","first-page":"120606","DOI":"10.1016\/j.envres.2024.120606","volume":"266","author":"M Sassano","year":"2025","unstructured":"Sassano M, Seyyedsalehi MS, Kappil EM et al (2025) Exposure to per- and poly-fluoroalkyl substances and lung, head and neck, and thyroid cancer: a systematic review and meta-analysis. Environ Res 266:120606. https:\/\/doi.org\/10.1016\/j.envres.2024.120606","journal-title":"Environ Res"},{"issue":"6","key":"11629_CR40","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1021\/envhealth.4c00268","volume":"3","author":"L He","year":"2025","unstructured":"He L, Liu C, Zhao H et al (2025) Unveiling the hidden threat: per- and polyfluoroalkyl substance pollution\u2019s distinct traits and crucial impacts on lung function in Chinese Plateau populations. Environ Health (Washington, DC) 3(6):605\u2013615. https:\/\/doi.org\/10.1021\/envhealth.4c00268","journal-title":"Environ health (Washington, DC)"},{"key":"11629_CR41","doi-asserted-by":"publisher","first-page":"724192","DOI":"10.3389\/fphar.2021.724192","volume":"12","author":"M Niu","year":"2021","unstructured":"Niu M, Zhang B, Li L et al (2021) Targeting HSP90 inhibits proliferation and induces apoptosis through AKT1\/ERK pathway in lung cancer. Front Pharmacol 12:724192. https:\/\/doi.org\/10.3389\/fphar.2021.724192","journal-title":"Front Pharmacol"},{"issue":"1","key":"11629_CR42","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41419-025-07650-9","volume":"16","author":"Y Sui","year":"2025","unstructured":"Sui Y, Shen Z, Pan R et al (2025) AHSA1-HSP90AA1 complex stabilized IFI6 and TGFB1 promotes mitochondrial stability and EMT in EGFR-mutated lung adenocarcinoma under Osimertinib pressure. Cell Death Dis 16(1):298. https:\/\/doi.org\/10.1038\/s41419-025-07650-9","journal-title":"Cell Death Dis"},{"issue":"2","key":"11629_CR43","first-page":"187","volume":"7","author":"TC Liu","year":"2017","unstructured":"Liu TC, Jin X, Wang Y et al (2017) Role of epidermal growth factor receptor in lung cancer and targeted therapies. Am J Cancer Res 7(2):187\u2013202","journal-title":"Am J Cancer Res"},{"issue":"2","key":"11629_CR44","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1056\/NEJMoa1713137","volume":"378","author":"JC Soria","year":"2018","unstructured":"Soria JC, Ohe Y, Vansteenkiste J et al (2018) Osimertinib in untreated EGFR-mutated advanced non-small-cell lung cancer. N Engl J Med 378(2):113\u2013125. https:\/\/doi.org\/10.1056\/NEJMoa1713137","journal-title":"N Engl J Med"},{"issue":"21","key":"11629_CR45","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1056\/NEJMoa2306434","volume":"389","author":"D Planchard","year":"2023","unstructured":"Planchard D, J\u00e4nne PA, Cheng Y et al (2023) Osimertinib with or without Chemotherapy in EGFR-mutated advanced NSCLC. N Engl J Med 389(21):1935\u20131948. https:\/\/doi.org\/10.1056\/NEJMoa2306434","journal-title":"N Engl J Med"},{"issue":"1","key":"11629_CR46","doi-asserted-by":"publisher","first-page":"7066","DOI":"10.1038\/s41598-017-06128-9","volume":"7","author":"G Rao","year":"2017","unstructured":"Rao G, Pierobon M, Kim IK et al (2017) Inhibition of AKT1 signaling promotes invasion and metastasis of non-small cell lung cancer cells with K-RAS or EGFR mutations. Sci Rep 7(1):7066. https:\/\/doi.org\/10.1038\/s41598-017-06128-9","journal-title":"Sci Rep"},{"issue":"7","key":"11629_CR47","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1021\/acs.jnatprod.3c00384","volume":"86","author":"H Lin","year":"2023","unstructured":"Lin H, Ai D, Liu Q et al (2023) Modified podophyllotoxin phenoxyacetamide phenylacetate derivatives: tubulin\/AKT1 dual-targeting and potential anticancer agents for human NSCLC. J Nat Prod 86(7):1844\u20131854. https:\/\/doi.org\/10.1021\/acs.jnatprod.3c00384","journal-title":"J Nat Prod"},{"key":"11629_CR48","doi-asserted-by":"publisher","first-page":"1034750","DOI":"10.3389\/fonc.2022.1034750","volume":"12","author":"L Zhang","year":"2022","unstructured":"Zhang L, Gong Y, Zhang L et al (2022) Gou Qi Zi inhibits proliferation and induces apoptosis through the PI3K\/AKT1 signaling pathway in non-small cell lung cancer. Front Oncol 12:1034750. https:\/\/doi.org\/10.3389\/fonc.2022.1034750","journal-title":"Front Oncol"},{"issue":"5","key":"11629_CR49","doi-asserted-by":"publisher","first-page":"686","DOI":"10.6061\/clinics\/2013(05)17","volume":"68","author":"Y Jin","year":"2013","unstructured":"Jin Y, Zhao L, Peng F (2013) Prognostic impact of serum albumin levels on the recurrence of stage I non-small cell lung cancer. Clin (Sao Paulo Brazil) 68(5):686\u2013693. https:\/\/doi.org\/10.6061\/clinics\/2013(05)17","journal-title":"Clin (Sao Paulo Brazil)"},{"issue":"678","key":"11629_CR50","doi-asserted-by":"publisher","first-page":"eabl7895","DOI":"10.1126\/scitranslmed.abl7895","volume":"15","author":"L Su","year":"2023","unstructured":"Su L, Chen Y, Huang C et al (2023) Targeting Src reactivates pyroptosis to reverse chemoresistance in lung and pancreatic cancer models. Sci Transl Med 15(678):eabl7895. https:\/\/doi.org\/10.1126\/scitranslmed.abl7895","journal-title":"Sci Transl Med"},{"issue":"7","key":"11629_CR51","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/s41419-024-06919-9","volume":"15","author":"G Lin","year":"2024","unstructured":"Lin G, Lin L, Chen X et al (2024) PPAR-\u03b3\/NF-kB\/AQP3 axis in M2 macrophage orchestrates lung adenocarcinoma progression by upregulating IL-6. Cell Death Dis 15(7):532. https:\/\/doi.org\/10.1038\/s41419-024-06919-9","journal-title":"Cell Death Dis"},{"key":"11629_CR52","doi-asserted-by":"publisher","first-page":"8252796","DOI":"10.1155\/2017\/8252796","volume":"2017","author":"SP Lakshmi","year":"2017","unstructured":"Lakshmi SP, Reddy AT, Banno A et al (2017) PPAR agonists for the prevention and treatment of lung cancer. PPAR Res 2017:8252796. https:\/\/doi.org\/10.1155\/2017\/8252796","journal-title":"PPAR Res"},{"issue":"2","key":"11629_CR53","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3390\/biom14020190","volume":"14","author":"J Zhang","year":"2024","unstructured":"Zhang J, Tang M, Shang J (2024) PPAR\u03b3 modulators in lung cancer: molecular mechanisms, clinical prospects, and challenges. Biomolecules 14(2):190. https:\/\/doi.org\/10.3390\/biom14020190","journal-title":"Biomolecules"},{"issue":"4","key":"11629_CR54","first-page":"1247","volume":"33","author":"JJ Tsay","year":"2013","unstructured":"Tsay JJ, Tchou-Wong KM, Greenberg AK et al (2013) Aryl hydrocarbon receptor and lung cancer. Anticancer Res 33(4):1247\u20131256","journal-title":"Anticancer Res"},{"issue":"1","key":"11629_CR55","doi-asserted-by":"publisher","first-page":"7944","DOI":"10.1038\/s41598-021-86754-6","volume":"11","author":"F Mohamed","year":"2021","unstructured":"Mohamed F, Abdelaziz AO, Kasem AH et al (2021) Thyroid hormone receptor \u03b11 acts as a new squamous cell lung cancer diagnostic marker and poor prognosis predictor. Sci Rep 11(1):7944. https:\/\/doi.org\/10.1038\/s41598-021-86754-6","journal-title":"Sci Rep"},{"issue":"1","key":"11629_CR56","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12943-025-02333-7","volume":"24","author":"B Liu","year":"2025","unstructured":"Liu B, Tao W, Zhou X et al (2025) Multi\u2013omics analysis identifies different molecular subtypes with unique outcomes in early-stage poorly differentiated lung adenocarcinoma. Mol Cancer 24(1):129. https:\/\/doi.org\/10.1186\/s12943-025-02333-7","journal-title":"Mol Cancer"},{"issue":"1","key":"11629_CR57","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1038\/s41467-024-55068-2","volume":"16","author":"C Wang","year":"2025","unstructured":"Wang C, Li J, Chen J et al (2025) Multi-omics analyses reveal biological and clinical insights in recurrent stage I non-small cell lung cancer. Nat Commun 16(1):1477. https:\/\/doi.org\/10.1038\/s41467-024-55068-2","journal-title":"Nat Commun"},{"key":"11629_CR58","doi-asserted-by":"publisher","first-page":"109026","DOI":"10.1016\/j.compbiolchem.2026.109026","volume":"123","author":"S Ma","year":"2026","unstructured":"Ma S, Xu R, Lin C et al (2026) SFTPB: a signature gene for lung adenocarcinoma development. Comput Biol Chem 123:109026. https:\/\/doi.org\/10.1016\/j.compbiolchem.2026.109026","journal-title":"Comput Biol Chem"},{"issue":"4","key":"11629_CR59","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.7150\/thno.123679","volume":"16","author":"Y Ding","year":"2026","unstructured":"Ding Y, Tian Y, Li M et al (2026) Targeting CPS1 attenuates lung cancer metastasis by regulating EMT through an epigenetic mechanism. Theranostics 16(4):1740\u20131761. https:\/\/doi.org\/10.7150\/thno.123679","journal-title":"Theranostics"},{"issue":"2","key":"11629_CR60","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41556-025-01840-5","volume":"28","author":"L Wang","year":"2026","unstructured":"Wang L, Chu H, Chen D et al (2026) SLC2A1(+) tumour-associated macrophages spatially control CD8(+) T cell function and drive resistance to immunotherapy in non-small-cell lung cancer. Nat Cell Biol 28(2):338\u2013348. https:\/\/doi.org\/10.1038\/s41556-025-01840-5","journal-title":"Nat Cell Biol"},{"issue":"23","key":"11629_CR61","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1111\/1759-7714.15013","volume":"14","author":"X He","year":"2023","unstructured":"He X, Ma Y, Huang Z et al (2023) SERPINB5 is a prognostic biomarker and promotes proliferation, metastasis and epithelial-mesenchymal transition (EMT) in lung adenocarcinoma. Thorac cancer 14(23):2275\u20132287. https:\/\/doi.org\/10.1111\/1759-7714.15013","journal-title":"Thorac cancer"},{"issue":"2","key":"11629_CR62","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/sj.bjc.6602934","volume":"94","author":"K Hiraoka","year":"2006","unstructured":"Hiraoka K, Miyamoto M, Cho Y et al (2006) Concurrent infiltration by CD8\u2009+\u2009T cells and CD4\u2009+\u2009T cells is a favourable prognostic factor in non-small-cell lung carcinoma. Br J Cancer 94(2):275\u2013280. https:\/\/doi.org\/10.1038\/sj.bjc.6602934","journal-title":"Br J Cancer"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11629-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-026-11629-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11629-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T13:35:09Z","timestamp":1782221709000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-026-11629-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":62,"alternative-id":["11629"],"URL":"https:\/\/doi.org\/10.1007\/s11030-026-11629-9","relation":{},"ISSN":["1573-501X"],"issn-type":[{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"4 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}]}}